Large-cap stocks were the worst performers last week, with declines up to 23%. Reasons include revenue misses, FDA bans, and Uber’s stake monetization.
Large-cap stocks were the worst performers last week, with declines up to 23%. Reasons include revenue misses, FDA bans, and Uber’s stake monetization.
Copyright © Louis Velazquez. All Rights Reserved.